229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.69%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
0.69%
Positive gross profit growth while VUZI is negative. John Neff would see a clear operational edge over the competitor.
10.00%
EBIT growth 75-90% of VUZI's 11.13%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
10.00%
Operating income growth similar to VUZI's 10.47%. Walter Schloss would assume both share comparable operational structures.
8.20%
Net income growth at 50-75% of VUZI's 11.25%. Martin Whitman would question fundamental disadvantages in expenses or demand.
9.68%
EPS growth similar to VUZI's 9.09%. Walter Schloss would assume both have parallel share structures and profit trends.
13.33%
Diluted EPS growth 1.25-1.5x VUZI's 9.09%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.59%
Share count expansion well above VUZI's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-2.25%
Reduced diluted shares while VUZI is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
933.33%
Positive OCF growth while VUZI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
277.78%
Positive FCF growth while VUZI is negative. John Neff would see a strong competitive edge in net cash generation.
-32.46%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-55.64%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-28.29%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
248.42%
10Y OCF/share CAGR above 1.5x VUZI's 60.75%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-52.02%
Negative 5Y OCF/share CAGR while VUZI is at 51.30%. Joel Greenblatt would question the firm’s operational model or cost structure.
-34.48%
Negative 3Y OCF/share CAGR while VUZI stands at 12.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-42.95%
Negative 10Y net income/share CAGR while VUZI is at 33.50%. Joel Greenblatt sees a major red flag in long-term profit erosion.
87.45%
5Y net income/share CAGR above 1.5x VUZI's 14.04%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-52.09%
Negative 3Y CAGR while VUZI is 36.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
55.74%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
35.24%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
83.71%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Cut dividends over 10 years while VUZI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.07%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-42.11%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.82%
Negative asset growth while VUZI invests at 3.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.01%
Under 50% of VUZI's 2.76%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-4.92%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-4.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
